Altogether, our results indicated that the improvement of MetS and hepatic steatosis by LWE could be attributed to the activation of the SIRT6/SREBP1 /FAS/DGAT1 pathway to reduce lipogenesis. The gene discussed is SREBF1; the disease is fatty liver disease.